NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy

Stock Information for NovaBay Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
NovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through Amazon
NioBay Confirms Phosphate in Historic Vior Drill Holes on Foothills Property
NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
NioBay Announces Closing of the First Tranche of a Private Placement
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.